Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 7, keine Gesamtzahl für „treated“
Suchtreffer
Begriffe & Kennungen
Amsparity · 4.8 · The incidence of serious infections was 0.04 per patient year in adalimumab-treated patients and 0.03 per pati
Eintrag öffnenAmsparity · 4.8 · The incidence of serious infections was 0.04 per patient year in adalimumab-treated patients and 0.03 per pati
Eintrag öffnenAmsparity · 4.8 · The safety profile for patients with HS treated with adalimumab weekly was consistent with the known safety pr
Eintrag öffnenAmsparity · 4.8 · The safety profile for patients with HS treated with adalimumab weekly was consistent with the known safety pr
Eintrag öffnenAmsparity · 4.8 · The safety profile for patients with uveitis treated with adalimumab every other week was consistent with the
Eintrag öffnenAmsparity · 4.8 · The safety profile for patients with uveitis treated with adalimumab every other week was consistent with the
Eintrag öffnenAmsparity · 4.8 · The safety profile for patients with uveitis treated with adalimumab every other week was consistent with the
Eintrag öffnenAmvuttra · 4.8 · Immunogenicity In the HELIOS-A and HELIOS-B studies, 4 (3.3%) and 1 (0.3%) Amvuttra-treated patients, respecti
Eintrag öffnenAmvuttra · 4.8 · Liver function tests In the HELIOS-B study, 97 (30%) of patients treated with Amvuttra and 78 (24%) patients t
Eintrag öffnenApexelsin · 4.8 · 16 Human serum albumin-paclitaxel nanoparticles/gemcitabine For patients treated with human serum albumin-pacl
Eintrag öffnenApexelsin · 4.8 · Adverse reactions were assessed in 229 patients with metastatic breast cancer who were treated with 260 mg/m2
Eintrag öffnenApexelsin · 4.8 · Adverse reactions were assessed in 421 patients with metastatic pancreatic cancer who were treated with human
Eintrag öffnenApexelsin · 4.8 · Adverse reactions were assessed in 514 patients with non-small cell lung cancer who were treated with human se
Eintrag öffnenApexelsin · 4.8 · Human serum albumin-paclitaxel nanoparticles/carboplatin For non-small cell lung cancer patients treated with
Eintrag öffnenApixaban Accord · 4.5 · In study CV185325, no clinically important bleeding events were reported in the 12 paediatric patients treated
Eintrag öffnenApixaban Accord · 4.5 · In study CV185325, no clinically important bleeding events were reported in the 12 paediatric patients treated
Eintrag öffnenApixaban Accord · 4.8 · In the VTEp studies, in total, 11% of the patients treated with apixaban 2.5 mg twice daily experienced advers
Eintrag öffnenAprovel · 4.8 · 45 placebo-treated patients (4.5%). The incidence of adverse events was not related to dose (in the recommende
Eintrag öffnenAprovel · 4.8 · Very common: Hyperkalaemia* occurred more often in diabetic patients treated with irbesartan than with placebo
Eintrag öffnenAprovel · 4.8 · Very common: Hyperkalaemia* occurred more often in diabetic patients treated with irbesartan than with placebo
Eintrag öffnen